Suga Tablet 10 mg (Dapagliflozin Monohydrate Mixed Powder)

Adult dose

The recommended dosage of this medication for both monotherapy and additional combination therapy with other hypoglycemic agents such as insulin is 10 mg once daily. When this medication is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or insulin secretagogues may be considered to reduce the risk of hypoglycemia. For initial combination therapy, if there is no previous experience of diabetes medication treatment,

Child dose

The efficacy and safety of this medication in children under 18 years of age have not been established.

This medication should not be used in certain patients. Patients who are allergic to this medication's active ingredient or additives, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients with lactose intolerance should not take this medication. Also, patients undergoing dialysis should not use this medication. Patients with reduced fluid volume or renal dysfunction should use this medication cautiously. This medication may lower blood pressure or cause temporary changes in renal function; therefore, fluid status and renal function must be checked prior to administration, and caution should be taken to observe for symptoms of hypotension and renal function during use. Especially in patients with moderate to severe renal impairment, blood sugar control efficacy may be diminished. This medication contains colorants Yellow No. 4 and Yellow No. 5, so patients with allergies to these components should use it carefully. Various side effects may occur during treatment with this medication. The most common side effect is genital infections, which may occur more frequently in females. Other reported side effects include hypoglycemia, fluid volume reduction, dizziness, constipation, dry mouth, and urinary tract infections. This medication can affect renal function and may temporarily increase serum creatinine levels in some patients. Such changes may occur more frequently in patients with chronic kidney disease or in older adults, so caution is necessary. Rarely, serious infections like necrotizing fasciitis may occur, so if pain, swelling, or redness around the genital area appears, immediate consultation with healthcare professionals is necessary. This medication is not recommended for pregnant women, and administration should be discontinued immediately upon confirmation of pregnancy. Additionally, breastfeeding women should not use this medication. When used in conjunction with hypoglycemic agents such as insulin or sulfonylureas, there may be an increased risk of hypoglycemia; therefore, dose adjustment may be necessary when using these drugs together. There is no specific antidote for overdose; therefore, it is crucial to receive symptomatic treatment. Finally, this medication has not been established for safety and efficacy in children, so its use should be avoided. Close observation of hypoglycemia symptoms and fluid volume changes is important during treatment with this medication, and immediate consultation with a physician is necessary if any abnormal symptoms occur.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, mucosal pain in the mouth/eyes, difficulty breathing or dyspnea, asthma attacks, respiratory anomalies accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Vulvovaginitis
• balanitis and related genital infections
• urinary tract infections
• fungal infections
• hypoglycemia
• fluid volume reduction
• thirst
• dizziness
• constipation
• dry mouth

This medication may be sensitive to air and moisture; therefore, it must be stored in a tightly closed container. The recommended storage temperature is room temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication safely.

Appearance

Yellow, biconvex, diamond-shaped film-coated tablet

Package unit

28 tablets/box (14 tablets/PTP × 2, 7 tablets/PTP × 4), 30 tablets/bottle